Do physicians act differently when their patient outcomes are reported publicly? Some studies say yes and others no. Now, a new study adds to the confusion.
There's a dramatic flip-flop going on. The World Health Organization is now claiming that trans fats, which are found in margarine and donuts, are responsible for 500,000 deaths annually. Compare that to when partially-hydrogenated vegetable oil was saving us from butter and meat fat, which were also linked to cardiovascular disease. What changed? Not much – other than a hold on logic.
The latest guidelines in screening for prostate cancer are a win for patients and physicians. Talking with your doctor about these issues is the ultimate in personalized medicine and patient autonomy.
Is it time to re-examine concerns surrounding the intersection of patient privacy and a loved one seeking elected office?
We're possibly getting closer to saving thousands of newborns from a potentially nasty illness, and death. Novavax, a clinical-stage biotechnology company, states that it's reached a milestone in a clinical trial for the highly-anticipated vaccine for respiratory syncytial virus, or RSV.
First Lady Melania Trump underwent a "successful" embolization procedure for what was described as a "benign kidney condition." But if the condition is benign, why intervene?
American Council on Science and Health doctors and scientists are available for speaking engagements.
Because we are a non-profit we request an honorarium and expenses for events outside New York City or Washington DC.
To request a specific speaker, please provide details in an email to speakers@acsh.org
Using patient safety as a bargaining chip, and a tactic of delay, is unseemly at best and immoral at worst.
The trees that produce the cocoa beans that serve as the raw material of chocolate suffer from infections. The latest in gene editing technology may be used to produce infection resistant cacao trees, and, in doing so, keep our M&M and Snickers cravings met.
A major thread in public policy debates about the opioid crisis is an asserted need to “solve” it by limiting production of opioid analgesics, and reducing medical exposure to potentially addicting drugs. But will these steps produce a remedy? Will our addiction and overdose problems improve with such a one-size-fits-all policy? Almost certainly not.
